Literature DB >> 30374659

Predictors of low voltage areas in persistent atrial fibrillation: is it really a matter of time?

S Ammar-Busch1,2, A Buiatti3, A Tatzber4, T Reents4, F Bourier4, V Semmler4, M Telishevska4, G Hessling4, I Deisenhofer4.   

Abstract

BACKGROUND: Time has been postulated as an important factor for electrical remodeling of the left atrium (LA) in persistent atrial fibrillation (AF) ('AF begets AF'). However, it is still a matter of debate if structural changes are the cause or consequence of AF. We sought to determine the clinical and invasive parameters, which correlate with LA scar as determined by voltage mapping, in patients with persistent AF.
METHODS: Seventy consecutive patients undergoing ablation of persistent (49%) or long-standing persistent AF (51%), between January 2013 and February 2014, were enrolled in the study. Besides clinical parameters, 2D echocardiographic assessment of LA size and LA pressure (LAP) after transseptal puncture was also considered. Bipolar endocardial signals with a mean voltage amplitude < 0.1 mV during AF were defined as LA scar.
RESULTS: In the univariable analysis, LA scar was associated with age, gender, coronary artery disease (CAD), glomerular filtration rate (GFR), LA size and LAP. Arrhythmia duration, mild to moderate mitral regurgitation (MR), left ventricular dysfunction and left ventricular hypertrophy showed no significant correlation with atrial scar (all p > 0.05). In a multivariable regression model, LA scar area was independently associated with age, female gender and LA area. AF duration was not associated with LA scar.
CONCLUSIONS: In this study, older age, greater LA area and female gender predicted the degree of LA scar, while other variables tested did not. In particular, we found no significant association between AF duration and LA scar.

Entities:  

Keywords:  Atrial fibrillation; Low voltage; Three-dimensional mapping system

Mesh:

Year:  2018        PMID: 30374659     DOI: 10.1007/s10840-018-0471-7

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  6 in total

1.  [Pulmonary vein isolation using radiofrequency ablation].

Authors:  Leon Iden; Sonia Busch; Daniel Steven; Roland R Tilz; Dong-In Shin; K R Julian Chun; Heidi Estner; Felix Bourier; David Duncker; Philipp Sommer; Andreas Metzner; Tilman Maurer; Nils-Christian Ewertsen; Henning Jansen; Andreas Rillig; Victoria Johnson; Till Althoff
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2021-07-26

2.  The association between left atrial stiffness and low-voltage areas of left atrium in patients with atrial fibrillation.

Authors:  Hideyuki Kishima; Takanao Mine; Eiji Fukuhara; Kenki Ashida; Masaharu Ishihara
Journal:  Heart Vessels       Date:  2019-05-02       Impact factor: 2.037

3.  Responsiveness to bepridil predicts atrial substrate in patients with persistent atrial fibrillation.

Authors:  Daisuke Yakabe; Yusuke Fukuyama; Masahiro Araki; Toshihiro Nakamura
Journal:  J Arrhythm       Date:  2021-01-04

4.  Predictors of left atrial fibrosis in patients with atrial fibrillation referred for catheter ablation.

Authors:  Valentina A Rossi; Iva Krizanovic-Grgic; Jan Steffel; Daniel Hofer; Thomas Wolber; Corinna B Brunckhorst; Frank Ruschitzka; Firat Duru; Alexander Breitenstein; Ardan M Saguner
Journal:  Cardiol J       Date:  2022-03-14       Impact factor: 3.487

5.  The immediate trends in atrial electrical remodeling for paroxysmal atrial fibrillation across different modes of catheter ablation.

Authors:  Qian Hou; Liang Feng; Jing Yang; Yue Liu; Ling You; Lianxia Wang; Yan Zhang; Qian Liu; Yuliang Zhao; Ruiqin Xie
Journal:  Clin Cardiol       Date:  2021-06-01       Impact factor: 2.882

6.  Predictors of the voltage derived left atrial fibrosis in patients with long-standing persistent atrial fibrillation.

Authors:  Radoslaw M Kiedrowicz; Maciej Wielusinski; Andrzej Wojtarowicz; Jaroslaw Kazmierczak
Journal:  Cardiol J       Date:  2020-05-18       Impact factor: 3.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.